“…INTERVENTIONS: Randomization (1:1) to a 22-week qigong intervention (n = 136) that included 22 weeks of Baduanjin qigong group training (1-6 weeks: 2-hour sessions biweekly; 7-22 weeks: 1-hour follow-up sessions weekly) and self-practice (30 minutes per day for 22 weeks) or to a wait-list control group (n = 135) that received optional monthly health education sessions unrelated to qigong after 6 weeks (posttraining period) and qigong training after 22 weeks (postintervention period). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…To understand the current registration process and management of quality projects in the UF Health system a needs assessment was performed with the UF Health Sebastian Ferrero Office of Clinical Quality & Patient Safety to gather project requirements. Biweekly meetings were held between the Quality Improvement office and the Clinical and Translational Science – Informatics and Technology teams during the entire project. …”
Enlace del recurso
Enlace del recurso

“…Over the study period, farm visits occurred biweekly on consistent days, during which milk composition (specifically fat and protein) was measured using a BROLIS HerdLine in-line milk analyzer (Brolis Sensor Technology, Vilnius, Lithuania). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The immediate group received a brief education session by a physical therapist, a Fitbit Flex, and four biweekly phone calls for activity counseling. The delayed group received the same intervention 2 months later. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…INTERVENTIONS: Patient-supporter dyads received a health coaching session focused on dyadic information sharing and positive support techniques, then 12 months of biweekly automated monitoring telephone calls to prompt dyadic actions to meet diabetes goals, coaching calls to help dyads prepare for primary care visits, and after-visit summaries. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Decol involved nasal iodophor on admission x 5d and then M-F biweekly plus chlorhexidine for routine bathing for all residents. …”
Enlace del recurso
Enlace del recurso

“…Eligibility was assessed biweekly from electronic health record data, and adults with an incident International Classification of Diseases, 10(th) Revision (ICD-10) HZ diagnosis were invited to complete an online survey. …”
Enlace del recurso
Enlace del recurso

“…Decol consisted of 1) chlorhexidine bathing; 2) nasal povidone iodine bid on admission x 5d and then M-F biweekly x 18 mo. Primary outcome was the probability that a transfer to a hospital was due to infection. …”
Enlace del recurso
Enlace del recurso

“…METHODS: From July 2020 to February 2022, HCP at an academic medical center provided blood samples biweekly for 12 weeks and monthly thereafter. First and second vaccine doses became available in mid-December 2021 and boosters were available starting in October 2021. …”
Enlace del recurso
Enlace del recurso

“…The PURE Study is an investigator-initiated study funded by the Population Health Research Institute, the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Ontario, support from CIHR’s Strategy for Patient Oriented Research (SPOR) through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithkline, and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries; these include: Argentina: Fundacion ECLA; Bangladesh: Independent University, Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Colombia: Colciencias, grant number 6566-04-18062; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia, grant numbers 100 -IRDC/BIOTEK 16/6/21 (13/2007) and 07-05-IFN-BPH 010, Ministry of Higher Education of Malaysia grant number 600 -RMI/LRGS/5/3 (2/2011), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); occupied Palestinian territory: the UN Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre, Canada; Philippines: Philippine Council for Health Research & Development; Poland: Polish Ministry of Science and Higher Education grant number 290/W-PURE/2008/0, Wroclaw Medical University; Saudi Arabia: the Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (research group number RG -1436-013); South Africa: the North-West University, SANPAD (SA and Netherlands Programme for Alternative Development), National Research Foundation, Medical Research Council of SA, The SA Sugar Association (SASA), Faculty of Community and Health Sciences (UWC); Sweden: grants from the Swedish state under the Agreement concerning research and education of doctors; the Swedish Heart and Lung Foundation; the Swedish Research Council; the Swedish Council for Health, Working Life and Welfare, King Gustaf V’s and Queen Victoria Freemasons Foundation, AFA Insurance, Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, grant from the Swedish State under the Läkar Utbildnings Avtalet agreement, and grant from the Västra Götaland Region; Turkey: Metabolic Syndrome Society, AstraZeneca, Turkey, Sanofi Aventis, Turkey; United Arab Emirates (UAE): Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai UAE. …”
Enlace del recurso
Enlace del recurso

“…Limaymanta, Universidad Nacional Mayor de San Marcos (Perú) Cezar Karpinski, Universidad Federal de Santa Catarina (Brasil) Clarissa Moreira dos Santos Schmidt, Universidad Federal Fluminense (Brasil) Concepción Mendo Carmona , Universidad Complutense de Madrid (España) Críspulo Travieso Rodríguez, Universidad de Salamanca (España) Cristina Fuentes Lara, Universidad Rey Juan Carlos (España) Cristóbal Urbano Salido, Universidad de Barcelona (España) Diana Lucio Arias, Pontificia Universidad Javeriana (Colombia) Edgar Bisset, Universidad Federal de Santa Catarina (Brasil) Elio Atenógenes Villaseñor García, Instituto Nacional de Estadística y Geografía (México) Elizabeth Huisa Veria , Universidad Nacional Mayor de San Marcos (Perú) Elke Köppen Prubmann , Universidad Nacional Autónoma de México (México) Elvira Julieta Miguelez Gonzalez, Universidad de Salamanca (España) Emilce Sena Correa , Universidad Nacional de Asunción (Paraguay) Emir José Suaiden, Universidad de Brasilia (Brasil) Esther Elena García Carpintero, Consejo Superior de Investigaciones Científicas (España) Fabiano Ferreira de Castro, Universidad Federal de San Carlos (Brasil) Federico Del Giorgio Solfa , Universidad Nacional de La Plata (Argentina) Filiberto Felipe Martínez Arellanoz , Universidad Nacional Autónoma de México (México) Flor de María Silvestre Estela, Universidad de Brasilia (Brasil) Francisco José García Peñalvo, Universidad de Salamanca (España)) Gerardo Ruiz López , Instituto Mexicano del Seguro Social (México) Graciela Martínez Gutiérrez, Universidad del Centro de México (México) Hadtyr Axheli García Ortega , Universidad Autónoma de San Luis Potosí (México) Héctor Alejandro Ramos Chávez, Universidad Nacional Autónoma de México (México) Héctor Edgar Buenrostro Mercado, Centro de Investigación e Innovación en Tecnología de la Información y comunicación (México) Héctor Guillermo Alfaro López, Universidad Nacional Autónoma de México (México) Hugo Alberto Figueroa Alcántara , Universidad Nacional Autónoma de México (México) Isabel Galina Russell, Universidad Nacional Autónoma de México (México) Isabel Villaseñor Rodríguez, Universidad Complutense de Madrid (España) Iuliana Botezan, Universidad Complutense de Madrid (España) Jaime Ríos Ortega, Universidad Nacional Autónoma de México (México) Javier Fernández Molina, Universidad de Alicante (España) Javier Tarango , Universidad Autónoma de Chihuahua (México) Jenny Teresita Guerra González, Universidad Nacional Autónoma de México (éxico) Jesús Francisco García Pérez, Universidad Nacional Autónoma de México (México) Jesús Robledano Arillo, Universidad Carlos III de Madrid (España) José Antonio Cordón García, Universidad de Salamanca (España) José Antonio Merlo Vega, Universidad de Salamanca (España) † José López Yepes, Universidad Complutense de Madrid (España) Juan Antonio Martínez Comeche, Universidad Complutense de Madrid (España) Juan José Calva González, Universidad Nacional Autónoma de México (México) Juan Miguel Castillo Fonseca, Universidad Autónoma de San Luis Potosí (México) Juan Miguel Palma Peña, Universidad Nacional Autónoma de México (México) Juan Voutssas Márquez, Universidad Nacional Autónoma de México (México) Laura Cristina Torres Martínez, Instituto Politécnico Nacional (ENBA) (México) Lina Escalona Ríos, Universidad Nacional Autónoma de México (México) Linair Maria Campos, Universidad Federal Fluminense (Brasil) Luis Fernando Ramos Simón, Universidad Complutense de Madrid (España) Luis Joyanes Aguilar, Universidad Pontificia de Salamanca (España) Luis Manuel Plaza Gómez, Consejo Superior de Investigaciones Científicas (España) Luis Manuel Vilches Blázquez, Instituto Politécnico Nacional (CIC) (México) Luis Manuel Plaza Gómez, Consejo Superior de Investigaciones Científicas (España) Luzia Sigoli Fernandes Costa, Universidad Federal de San Carlos (Brasil) Manuel Blázquez Ochando, Universidad Complutense de Madrid (España) Marco Brandão, Universidad Federal Fluminense (Brasil) María Antonia Ovalle Perandones, Universidad Complutense de Madrid (España) Maria Cristina P. …”
Enlace del recurso
Enlace del recurso

“…Dalbavancin (DALBA) is a lipoglycopeptide with a very long half-life that allows the treatment of serious infections with once weekly or biweekly administration. We evaluated the activity of DALBA against pathogens isolated from BJI. …”
Enlace del recurso
Enlace del recurso